The polymorphisms of interleukin-10 gene influence the prognosis of patients with advanced melanoma

Cancer Genetics and Cytogenetics

Volumn 176, Issue 1, 2007, Pages 54-57

  Vuoristo, Meri Sisko ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ADULT; ADVANCED CANCER; AGED; ALLELE; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA POLYMORPHISM; FEMALE; HAPLOTYPE; HAZARD RATIO; HUMAN; MALE; MELANOMA; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMOTER REGION; RECURRENCE RISK; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS (GENETICS); SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 34250159828     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2007.03.002     Document Type: Article

References (16)

1. Asadullah K., Sterry W., and Volk H.D. Interleukin-10 therapy - review of a new approach. Pharmacol Rev 55 (2003) 241-269
2. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., and Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24 (1997) 1-8
3. Perrey C., Pravica V., Sinnott P.J., and Hutchinson I.V. Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-ß1 and tumour necrosis factor-α genes: a technical report. Transplant Immunol 6 (1998) 193-197
4. Howell W.M., and Rose-Zerilli M.J. Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Fam Cancer 5 (2006) 143-149
5. Howell W.M., Turner S.J., Bateman A.C., and Theaker J.M. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma. Genes Immunity 2 (2001) 25-31
6. Martinez-Escribano J.A., Moya-Quiles M.R., Muro M., Montes-Ares O., Hernandez-Caselles T., Frias J.F., and Alvarez-Lopez M.R. Interleukin-10, interleukin-6 and interferon-(gamma) gene polymorphisms in melanoma patients. Melanoma Res 12 (2002) 465-469
7. Alonso R., Suarez A., Castro P., Lacave A.J., and Gutierrez C. Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease. Melanoma Res 15 (2005) 53-60
8. Liu D., O'Day S.J., Yang D., Boasberg P., Milford R., Kristedja T., Groshen S., and Weber J. Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study. Clin Cancer Res 11 (2005) 1237-1246
9. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
10. Mok C.C., Lanchbury J.S., Chan D.W., and Lau C.S. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum 41 (1998) 1090-1095
11. Edwards-Smith C.J., Jonsson J.R., Purdie D.M., Bansal A., Shorthouse C., and Powell E.E. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alpha. Hepatology 30 (1999) 526-530
12. Matsuda M., Salazar F., Petersson M., Masucci G., Hansson J., Pisa P., Zhang Q.J., Masucci M.G., and Kiessling R. Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180 (1994) 2371-2376
13. Yue F.Y., Dummer R., Geertsen R., Hofbauer G., Laine E., Manolio S., and Burg G. Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer 71 (1997) 630-637
14. Nemunaitis J., Fong T., Shabe P., Martineau D., and Ando D. Comparison of serum interleukin-10 (IL-10) levels between normal volunteers and patients with advanved melanoma. Cancer Invest 19 (2001) 239-247
15. Huang S., Ullrich S.E., and Bar-Eli M. Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J Interferon Cytokine Res 19 (1999) 697-703
16. Tarhini A.A., and Agarwala S.S. Cutaneous melanoma: available therapy for metastatic disease. Dermatol Ther 19 (2006) 19-25